Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-01 Sale |
2022-03-02 8:40 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $17.59 | $175,900 | 609,864 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 7:12 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $17.56 | $175,600 | 619,864 (Direct) |
View |
| 2022-01-14 Sale |
2022-01-18 9:48 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $22.03 | $213,691 | 317,606 (Direct) |
View |
| 2021-01-10 Sale |
2022-01-11 9:40 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $19.55 | $195,500 | 619,864 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 9:03 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $22 | $2,200 | 327,306 (Direct) |
View |
| 2021-12-17 Sale |
2021-12-20 4:54 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $22.04 | $70,528 | 327,406 (Direct) |
View |
| 2021-12-02 Sale |
2021-12-03 5:20 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $20.18 | $353,150 | 255,996 (Direct) |
View |
| 2021-11-03 Sale |
2021-11-05 4:17 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
25,000 | $24.28 | $607,123 | 195,510 (Indirect Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 4:16 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $22.57 | $394,975 | 273,496 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:15 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $22.24 | $144,560 | 330,606 (Direct) |
View |
| 2021-10-15 Sale |
2021-10-18 4:21 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
12,500 | $21.59 | $269,826 | 120,921 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-05 4:11 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $21.54 | $376,950 | 290,996 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 4:10 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $22.06 | $143,367 | 337,106 (Direct) |
View |
| 2021-09-15 Sale |
2021-09-17 4:05 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
12,500 | $24.69 | $308,605 | 133,421 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 4:38 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $24.04 | $300,500 | 220,510 (Indirect Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 4:38 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $24 | $205,416 | 343,606 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-03 4:37 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $23.89 | $418,075 | 308,496 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-17 9:15 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $18.79 | $187,900 | 145,921 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:39 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $22.03 | $97,835 | 352,165 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 5:38 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $20.83 | $364,577 | 325,996 (Direct) |
View |
| 2021-07-15 Sale |
2021-07-19 4:43 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
10,000 | $20.9 | $209,044 | 155,921 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-09 Option Award |
2022-09-13 9:14 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
58,148 | $0 | 91,651 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
1,152 | $8.03 | 91,651 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:14 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
58,148 | $0 | 333,559 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,152 | $8.03 | 333,559 (Direct) |
View |
| 2021-06-30 Option Award |
2022-09-13 9:14 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
1,007 | $21.09 | 333,559 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:13 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
174,442 | $0 | 571,811 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,152 | $8.03 | 571,811 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:25 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 8:40 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 609,864 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 8:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 609,864 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 7:12 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 619,864 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 7:12 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 619,864 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-18 9:48 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $0 | 317,606 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-18 9:48 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
9,700 | $7.009 | 317,606 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 9:40 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 619,864 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 9:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 619,864 (Direct) |
View |
| 2022-01-07 Exercise |
2022-01-11 4:40 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
27,744 | $0 | 316,074 (Direct) |
View |
| 2022-01-07 Exercise |
2022-01-11 4:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
27,744 | $0.615 | 316,074 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:21 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
53,000 | $0 | 514,708 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:21 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
53,000 | $0.615 | 514,708 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 9:03 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $0 | 327,306 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 9:03 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
100 | $7.009 | 327,306 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 4:54 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $0 | 327,406 (Direct) |
View |
| 2021-12-17 Exercise |
2021-12-20 4:54 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
3,200 | $7.009 | 327,406 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:15 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
261,662 | $0 | 261,662 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:08 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:08 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:07 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:06 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
87,221 | $0 | 87,221 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:15 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 330,606 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:15 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 330,606 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 4:10 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $0 | 337,106 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 4:10 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
6,500 | $7.009 | 337,106 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:38 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $0 | 343,606 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:38 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
8,559 | $7.009 | 343,606 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 5:39 pm |
N/A 2029-04-04 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $0 | 352,165 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-04 5:39 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
4,441 | $7.009 | 352,165 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
9,000 | $0 | 259,306 (Direct) |
View |
| 2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
9,000 | $0.615 | 259,306 (Direct) |
View |